SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-042513
Filing Date
2019-02-15
Accepted
2019-02-15 16:44:34
Documents
1
Group Members
ERIC ROBERTSEVGENY ZAYTSEVGRAHAM CROOKEPHILIP SAWYERRACHEL LEHENYVALENCE HELIX INVESTMENTS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d709606dsc13d.htm SC 13D 153344
  Complete submission text file 0001193125-19-042513.txt   155132
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90188 | Film No.: 19612096
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 590 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10022 212-521-4379
Valence Helix Investments III, LLC (Filed by) CIK: 0001767901 (see all company filings)

IRS No.: 833347149 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D